These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 3324336)

  • 21. Fish vaccine antigens produced or delivered by recombinant DNA technologies.
    Leong JC; Anderson E; Bootland LM; Chiou PW; Johnson M; Kim C; Mourich D; Trobridge G
    Dev Biol Stand; 1997; 90():267-77. PubMed ID: 9270855
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conclusions--future trends in veterinary vaccinology.
    Pastoret PP; Schudel AA; Lombard M
    Rev Sci Tech; 2007 Aug; 26(2):489-94, 495-501, 503-9. PubMed ID: 17892169
    [No Abstract]   [Full Text] [Related]  

  • 23. Standardization or tailorization of veterinary vaccines: a conscious endeavour against infectious disease of animals.
    Tollis M
    Ann Ist Super Sanita; 2006; 42(4):446-9. PubMed ID: 17361069
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Challenges and opportunities in developing and marketing vaccines for OIE List A and emerging animal diseases.
    Gay CG; Salt J; Balaski C
    Dev Biol (Basel); 2003; 114():243-50. PubMed ID: 14677694
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vaccine potential of recombinant Ornithobacterium rhinotracheale antigens.
    Schuijffel DF; Van Empel PC; Segers RP; Van Putten JP; Nuijten PJ
    Vaccine; 2006 Mar; 24(11):1858-67. PubMed ID: 16318896
    [TBL] [Abstract][Full Text] [Related]  

  • 26. USDA comments on efficacy requirements for veterinary vaccines.
    Hill RE; Karli SA;
    J Am Vet Med Assoc; 2003 Aug; 223(4):430, 432; discussion 432. PubMed ID: 12930071
    [No Abstract]   [Full Text] [Related]  

  • 27. [Note on Point II of the agenda: principles according to which veterinary services may be organized for effective prevention of contagious diseases of economic importance].
    Bull Off Int Epizoot; 1966 May; 66(1):257-63. PubMed ID: 6011892
    [No Abstract]   [Full Text] [Related]  

  • 28. A survey of vaccines produced for OIE list A diseases in OIE member countries.
    Roth JA; Spickler AR
    Dev Biol (Basel); 2003; 114():5-25. PubMed ID: 14677673
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exploring the foundations of population health and preventive medicine as essential elements for veterinary education.
    Hooper BE
    Prev Vet Med; 2008 Sep; 86(3-4):179-87. PubMed ID: 18420292
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Risk analysis rules for the establishing of maximum residue limits of veterinary medicinal products].
    Zmudzki J
    Rocz Panstw Zakl Hig; 2003; 54 Suppl():12-3. PubMed ID: 12884488
    [No Abstract]   [Full Text] [Related]  

  • 31. Alternatives to the use of animals in R & D and quality control of veterinary vaccines: an industry view.
    Verschueren C; Zänker S
    Dev Biol Stand; 1996; 86():49-51. PubMed ID: 8785991
    [No Abstract]   [Full Text] [Related]  

  • 32. DNA vaccination: antigen presentation and the induction of immunity.
    Shedlock DJ; Weiner DB
    J Leukoc Biol; 2000 Dec; 68(6):793-806. PubMed ID: 11129646
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Veterinary medicine and game biology].
    Schulze H
    Dtsch Tierarztl Wochenschr (1946); 1967 Apr; 74(8):201-3. PubMed ID: 5627896
    [No Abstract]   [Full Text] [Related]  

  • 34. [The job and the way of working of the veterinarians in mass vaccination: what is the decision of the court?].
    de Kruif A; Verdonck M
    Tijdschr Diergeneeskd; 2004 Jul 15-Aug 1; 129(14-15):474-81. PubMed ID: 15344822
    [No Abstract]   [Full Text] [Related]  

  • 35. Marker vaccines and the impact of their use on diagnosis and prophylactic measures.
    Vannie P; Capua I; Le Potier MF; Mackay DK; Muylkens B; Parida S; Paton DJ; Thiry E
    Rev Sci Tech; 2007 Aug; 26(2):351-72. PubMed ID: 17892157
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Giardia intestinalis: conservation of the variant-specific surface protein VSP417-1 (TSA417) and identification of a divergent homologue encoded at a duplicated locus in genetic group II isolates.
    Ey PL; Darby JM
    Exp Parasitol; 1998 Nov; 90(3):250-61. PubMed ID: 9806870
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Progress in the development of new vaccines against tuberculosis.
    Orme IM
    Int J Tuberc Lung Dis; 1997 Apr; 1(2):95-100. PubMed ID: 9441089
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Contemporary vaccinology--scientific and practical aspects].
    Piotrowska-Jastrzebska J; Mikołuć B; Motkowski R
    Pol Merkur Lekarski; 2002 Jun; 12(72):526-9. PubMed ID: 12362676
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Organization, sequence, and function of 34.5 kb of genomic DNA encompassing several murine T-cell receptor alpha/delta variable gene segments.
    Seto D; Koop BF; Deshpande P; Howard S; Seto J; Wilk E; Wang K; Hood L
    Genomics; 1994 Mar; 20(2):258-66. PubMed ID: 8020973
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Veterinary medicine aspects relative to the problem of raising animals for income on a large scale (commercial raising)].
    Rojahn A
    Bull Off Int Epizoot; 1968; 69(11):2063-78. PubMed ID: 5761299
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.